Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1768170.
- Also identified by PMC identifier 1004592.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 49 year old white woman with systemic lupus erythematosus and bronchiolitis obliterans was treated with prednisone (1 mg/kg daily), which led to a transitory improvement in pulmonary status. Cyclophosphamide was then added--4 mg/kg daily intravenously for five days, then 2 mg/kg daily orally--and this was followed by a dramatic and prolonged improvement.
Medical subject headings
- Bronchiolitis Obliterans
- Cyclophosphamide
- Lupus Erythematosus, Systemic